Skip to main content
SpringerLink
Log in

Legislative Measures’ Impact on the New Psychoactive Substances Market

  • Chapter
  • First Online:
Book cover Dual Markets

Abstract

While much has been learned about the impact of various government interventions in the markets for traditionally illicit drugs, the recreational drug markets that operate in a legal gray area are often overlooked in contemporary research. This chapter examines how government interventions on illicit drugs have created a separate market of New Psychoactive Substances (NPSs), more commonly known as “legal highs.” To restrict the sale and use of these products, governments have used several legislative approaches, including banning individual NPSs on a case-by-case basis and banning entire groups/analogs of NPSs, all with varying degrees of success. Governments have also created new measures such as temporary banning orders as well as attempted to regulate low-risk products to better handle the problems resulting from NPS use. This chapter examines some of the strengths and weaknesses of these different approaches as well as examines some of their unintended consequences. The chapter concludes by providing an overview of some of the reasons against what some researchers have deemed to be an overregulation of this market. Finally, a case study of the once popular NPS mephedrone is used to illustrate the impact that regulatory changes on this product had on the mephedrone market.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Notes

  1. 1.

    It is worth noting that synthetic cathinones, which are often found in “legal highs” marketed as “bath salts,” are chemically related to the stimulant found in the khat plant, which is sometimes chewed by people in east Africa for its mild stimulant effect.

References

  • Advisory Council on the Misuse of Drugs (ACMD). (2011). Consideration of the novel psychoactive substances (‘legal highs’) (1st ed.). Home Office. London.

    Google Scholar 

  • Alexandrescu, L. (2014). Mephedrone, assassin of youth: The rhetoric of fear in contemporary drug scares. Crime, Media, Culture, 10(1), 23–37.

    Article  Google Scholar 

  • Babor, T., Caetano, R., Casswell, S., Edwards, G., Giesbrecht, N., Graham, K., et al. (2010). Alcohol: No ordinary commodity – a summary of the second edition. Addiction, 105(5), 769–779.

    Article  Google Scholar 

  • Barratt, M. J., Cakic, V., & Lenton, S. (2013). Patterns of synthetic cannabinoid use in Australia. Drug and Alcohol Review, 32(2), 141–146.

    Article  Google Scholar 

  • Boyer, E. W., Shannon, M., & Hibberd, P. L. (2005). The Internet and psychoactive substance use among innovative drug users. Pediatrics, 115(2), 302–305.

    Article  Google Scholar 

  • Carhart-Harris, R. L., King, L. A., & Nutt, D. J. (2011). A web-based survey on mephedrone. Drug and Alcohol Dependence, 118(1), 19–22.

    Article  Google Scholar 

  • Chatwin, C. (2013). A critical evaluation of the European drug strategy: Has it brought added value to drug policy making at the national level? The International Journal on Drug Policy, 24(3), 251–256.

    Article  Google Scholar 

  • Coulson, C., & Caulkins, J. P. (2012). Scheduling of newly emerging drugs: A critical review of decisions over 40 years. Addiction, 107(4), 766–773.

    Article  Google Scholar 

  • Davies, S., Wood, D. M., Smith, G., et al. (2010). Purchasing ‘legal highs’ on the internet – Is there consistency in what you get? QJM, 103, 489–493.

    Article  Google Scholar 

  • De Paoli, G., Maskell, P. D., & Pounder, D. J. (2011). Naphyrone: Analytical profile of the new “legal high” substitute for mephedrone. Journal of Forensic and Legal Medicine, 18(2), 93.

    Article  Google Scholar 

  • Dick, D., & Torrance, C. (2010). Mixmag drugs survey. Mixmag, 225, 44–53.

    Google Scholar 

  • Eastwood, N. (2010). Legal eye. Drugs and Alcohol Today, 10(2), 6–9.

    Article  Google Scholar 

  • EMCDDA. (2012). European Monitoring Centre for Drugs and Drug Addiction: Annual report on the state of the drugs problem in Europe. Lisbon.

    Google Scholar 

  • Europol-EMCDDA. (2010). Europol–EMCDDA Joint Report on a new psychoactive substance: 4-methylmethcathinone (mephedrone). Lisbon: European Monitoring Centre for Drugs and Drug Addiction. Chicago.

    Google Scholar 

  • Henderson, G. L. (1988). Designer drugs: past history and future prospects. Journal of Forensic Sciences, 33(2), 569–575.

    Article  Google Scholar 

  • Hughes, B., & Blidaru, T. (2009). Legal responses to new psychoactive substances in Europe. Lisbon: European Legal Database on Drugs, EMCDDA.

    Google Scholar 

  • Kau, G. (2008). Flashback to the Federal Analog Act of 1986: Mixing rules and standards in the Cauldron. University of Pennsylvania Law Review, 156(4), 1077–1115.

    Google Scholar 

  • King, L. (2013). Legal classification of novel psychoactive substances: An international comparison. In P. Dargan & D. Wood (Eds.), Novel psychoactive substances: Classification, pharmacology and toxicology (pp. 3–27). Amsterdam: Academic.

    Chapter  Google Scholar 

  • King, L. A., & Kicman, A. T. (2011). A brief history of ‘new psychoactive substances’. Drug Testing and Analysis, 3(7–8), 401–403.

    Article  Google Scholar 

  • King, L.A., Nutt, D.J., Singleton, N., & Howard, R. (2012). Analogue controls: An imperfect law. UK Drug Policy Commission and Independent Scientific Committee on Drugs.

    Google Scholar 

  • Loeffler, G., Delaney, E., & Hann, M. (2016). International trends in spice use: Prevalence, motivation for use, relationship to other substances, and perception of use and safety for synthetic cannabinoids. Brain Research Bulletin, 126, 8–28.

    Article  Google Scholar 

  • Long, J., & Connolly, J. (2011). Report on new psychoactive substances and the outlets supplying them. Drugnet Ireland., 39, 9–10.

    Google Scholar 

  • MacCoun, R., & Reuter, P. (2001). Evaluating alternative cannabis regimes. British Journal of Psychiatry, 178, 123–128.

    Article  Google Scholar 

  • McVeigh, K. (2015, June). Is Irish ban on legal highs driving markets underground? The Guardian, 30, 2015.

    Google Scholar 

  • Measham, F., Moore, K., Newcombe, R., & Née Smith, Z. (2010). Tweaking, bombing, dabbing and stockpiling: The emergence of mephedrone and the perversity of prohibition. Drugs and Alcohol Today, 10(1), 14–21.

    Article  Google Scholar 

  • Measham, F., Moore, K., & Østergaard, J. (2011). Mephedrone, ‘bubble’ and unidentified white powders: The contested identities of synthetic ‘legal highs’. Drugs and Alcohol Today, 11, 137–146.

    Article  Google Scholar 

  • Ministry of Health. (2012). Regulatory Impact Statement—New regulatory regime for psychoactive substances. Wellington.

    Google Scholar 

  • Miserez, B., Ayrton, O., & Ramsey, J. (2014). Analysis of purity and cutting agents in street mephedrone samples from South Wales. Forensic Toxicology, 32(2), 305–310.

    Article  Google Scholar 

  • Noller, G. (2014). Synthetic cannabinoid use in New Zealand: Assessing the harms. Substance Use and Policy Analysis: Dunedin.

    Google Scholar 

  • Nutt, D. (2012). Drugs—Without the hot air: Minimising the harms of legal and illegal drugs. Cambridge: UIT.

    Google Scholar 

  • Seddon, T. (2014). Drug policy and global regulatory capitalism: The case of new psychoactive substances (NPS). The International Journal on Drug Policy, 25(5), 1019–1024.

    Article  Google Scholar 

  • Smith, S., & Garlich, F. (2013). Availability and supply of novel psychoactive substances. In P. Dargan & D. Wood (Eds.), Novel psychoactive substances: Classification, pharmacology and toxicology (pp. 55–77). Amsterdam: Academic.

    Chapter  Google Scholar 

  • Soussan, C., & Kjellgren, A. (2016). The users of Novel Psychoactive Substances: Online survey about their characteristics, attitudes and motivations. The International Journal on Drug Policy, 32, 77–84.

    Article  Google Scholar 

  • Taylor, J. (2015). The stimulants of Prohibition: Illegality and new synthetic drugs. Territory, Politics, Governance, 3(4), 407–427.

    Article  Google Scholar 

  • UNODC. (2013). The challenge of New Psychoactive Substances 2013. United Nations Office on Drugs and Crime (UNODC).

    Google Scholar 

  • UNODC. (2015). World drug report. New York: United Nations.

    Google Scholar 

  • UNODC. (2016). World drug report. New York: United Nations.

    Google Scholar 

  • van Amsterdam, J., Nutt, D., & van den Brink, W. (2013). Generic legislation of new psychoactive drugs. Journal of Psychopharmacology, 27(3), 317–324.

    Article  Google Scholar 

  • Van Hout, M. C., & Brennan, R. (2011). ‘Heads held high’: An exploratory study of legal highs in pre-legislation Ireland. Journal of Ethnicity in Substance Abuse, 10(3), 256–272.

    Article  Google Scholar 

  • Van Hout, M. C., & Brennan, R. (2012). Curiosity killed M-Cat: A post-legislative study on mephedrone use in Ireland. Drugs: Education, Prevention and Policy,19(2), 156-162.

    Google Scholar 

  • Vardakou, I., Pistos, C., & Spiliopoulou, C. (2011). Drugs for youth via Internet and the example of mephedrone. Toxicology Letters, 201(3), 191–195.

    Article  Google Scholar 

  • Vince, G. (2006). Mind altering drugs: Does legal mean safe? New Scientist, 191(2571), 40–45.

    Article  Google Scholar 

  • Wiecko, F. M., Thompson, W. E., & Parham, B. P. (2016). A high by any other name: Exploring the motivations for consumption of “legal highs”. Deviant Behavior, 1–12.

    Google Scholar 

  • Wilkins, C. (2014). A critical first assessment of the new pre-market approval regime for new psychoactive substances (NPS) in New Zealand. Addiction, 109(10), 1580–1586.

    Article  Google Scholar 

  • Wilkins, C., Girling, M., & Sweetsur, P. (2007). The prevalence of use, dependency and harms of legal ‘party pills’ containing benzylpiperazine (BZP) and trifluorophenylmethylpiperazine (TFMPP) in New Zealand. Journal of Substance Use, 12(3), 213–224.

    Article  Google Scholar 

  • Wilkins, C., Sheridan, J., Adams, P., Russell, B., Ram, S., & Newcombe, D. (2013). The new psychoactive substances regime in New Zealand: A different approach to regulation. Journal of Psychopharmacology, 27(7), 584–589.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Criminology, University of Leicester, Leicester, UK

    Maurits T. Beltgens

Authors
  1. Maurits T. Beltgens
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Maurits T. Beltgens .

Editor information

Editors and Affiliations

  1. Transcrime, Università Cattolica del Sacro Cuore, Milan, Italy

    Ernesto U. Savona

  2. Marron Institute of Urban Management, New York University, New York, New York, USA

    Mark A.R. Kleiman

  3. Transcrime, Università Cattolica del Sacro Cuore, Milan, Italy

    Francesco Calderoni

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Beltgens, M.T. (2017). Legislative Measures’ Impact on the New Psychoactive Substances Market. In: Savona, E., Kleiman, M., Calderoni, F. (eds) Dual Markets. Springer, Cham. https://doi.org/10.1007/978-3-319-65361-7_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-65361-7_10

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-65360-0

  • Online ISBN: 978-3-319-65361-7

  • eBook Packages: Law and CriminologyLaw and Criminology (R0)

Publish with us

Policies and ethics

Search

Navigation